Protherics PLC
6 monthly Block Listing Return in respect of
6% unsecured convertible loan notes
London, UK; Brentwood, TN, US: 9 August 2007 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that the following
6 monthly block listing return in respect of the Company's 6% unsecured
convertible loan notes has been lodged with the FSA today, in accordance
with Listing Rule 3.5.6.
Name of applicant: Protherics PLC
Name of scheme: Block Listing in respect of 6% Unsecured
Convertible Loan Notes
Period of return: From: 9 February 2006 To: 8 August 2007
Balance under scheme 8,917,396 Ordinary Shares (Loan Notes to the
from previous return: value of GBP2,229,349.00)
The amount by which the
block scheme has been
increased, if the scheme
has been increased since
the date of the last
return: Nil
Number of securities
issued/allotted under
scheme during 78,236 Ordinary Shares (Loan Notes to the value
period: of GBP19,559.00)
Balance under scheme not
yet issued/allotted at 8,839,160 Ordinary Shares (Loan Notes to the
end of period value of GBP2,209,790.00
Number and class of
securities originally 17,092,476 Ordinary Shares (Loan Notes to the
listed and the date of value of GBP4,273,119.00) admitted on 8
admission February 2005
Total number of securities in issue at the end of the period
339,243,653 Ordinary Shares
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518000
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Blocklisting Interim Review
| Source: Protherics PLC
Cheshire, UK--(Marketwire - August 9, 2007) -